What Are the Key Drivers Behind the Adoption of Nanobodies by Pharmaceutical & Biotechnology Companies?
Pharmaceutical and biotechnology companies are rapidly adopting nanobodies due to their unique advantages over traditional antibodies. Nanobodies are small, single-domain antibodies derived from heavy-chain-only antibodies found in animals like camels and llamas.
Their small size allows...
The global targeted cancer therapies market is estimated to be valued at US$ 1603.7 Mn in 2023 and is expected to exhibit a CAGR of 9.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: Targeted cancer therapies are more effective with fewer side effects than traditional chemotherapy...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian